DELVE Trademark

Trademark Overview


On Monday, March 12, 2018, a trademark application was filed for DELVE with the United States Patent and Trademark Office. The USPTO has given the DELVE trademark a serial number of 87830793. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, January 22, 2019. This trademark is owned by SHEPHERD Therapeutics. The DELVE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

SHEPHERD uses a proprietary software, DELVE, that combines deep learning artificial intelligence and proprietary algorithms with traditional quantitative and qualitative statistical analysis. We start by mapping the mutational landscape (every known target and pathway) of every rare cancer, then add in significant qualitative variables related to patient profile, environmental data, and demographics to inform the best treatment modality.Ã, Our ability to identify target overlap, combined with our deep knowledge of each cancer, allows us to engineer an optimal therapeutic combination and delivery technology for multiple rare cancers
delve

General Information


Serial Number87830793
Word MarkDELVE
Filing DateMonday, March 12, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, January 22, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesSHEPHERD uses a proprietary software, DELVE, that combines deep learning artificial intelligence and proprietary algorithms with traditional quantitative and qualitative statistical analysis. We start by mapping the mutational landscape (every known target and pathway) of every rare cancer, then add in significant qualitative variables related to patient profile, environmental data, and demographics to inform the best treatment modality.Ã, Our ability to identify target overlap, combined with our deep knowledge of each cancer, allows us to engineer an optimal therapeutic combination and delivery technology for multiple rare cancers

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 29, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSHEPHERD Therapeutics
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAntioch, TN 37013

Trademark Events


Event DateEvent Description
Tuesday, January 22, 2019ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, January 22, 2019ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, June 26, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 26, 2018NON-FINAL ACTION E-MAILED
Tuesday, June 26, 2018NON-FINAL ACTION WRITTEN
Friday, June 22, 2018ASSIGNED TO EXAMINER
Thursday, March 29, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, March 15, 2018NEW APPLICATION ENTERED IN TRAM